TIS-U-SOL (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the TIS-U-SOL drug offered from Baxter Healthcare Corporation. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | sodium chloride, potassium chloride, magnesium sulfate, sodium phosphate, and potassium phosphate |
| SUBSTANCE NAME: | SODIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; POTASSIUM PHOSPHATE, MONOBASIC |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | IRRIGATION |
| DOSAGE FORM: | IRRIGANT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1982-02-19 |
| END MARKETING DATE: | 0000-00-00 |
TIS-U-SOL HUMAN PRESCRIPTION DRUG Details:
| Item Description | TIS-U-SOL from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 800; 40; 20; 8.75; 6.25(mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL) |
| START MARKETING DATE: | 1982-02-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0338-0190_534b85e0-04e7-4652-a948-244b9d382f7d |
| PRODUCT NDC: | 0338-0190 |
| APPLICATION NUMBER: | NDA018508 |
Other SODIUM CHLORIDE; POTASSIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; POTASSIUM PHOSPHATE, MONOBASIC Pharmaceutical Manufacturers / Labelers:
